Please login to the form below

Not currently logged in
Email:
Password:

Tretten

This page shows the latest Tretten news and features for those working in and with pharma, biotech and healthcare.

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten. Becomes first recombinant treatment licensed for a rare clotting disorder. ... Novo Nordisk said Tretten is expected to be launched in the US early next year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics